FDA
-
-
-
-
-
-
-
OraSure Submits CT/NG Molecular Self-Test and Colli-Pee™ Urine Collection Device for FDA Review
-
-
-
-
-
-
-
OraSure Reports Fourth Quarter 2024 Financial Results
-
-
-
-
-
-
-
OraSure Reports Q3 ’24 Revenue of $39.9 Million
-
-
-
-
-
-
-
OraSure Reports Q4 ‘23 Revenue of $75.9 Million
-
-
-
-
-
-
-
OraSure Technologies Elects Robert McMahon to the Board of Directors
-
-
-
-
-
-
-
OraSure Reports 3Q22 Record Revenue of $116.5 Million Growing 116% Year-Over-Year
-
-
-
-
-
-
-
OraSure Technologies Receives $8.6 Million BARDA Contract to Develop 2nd Generation Ebola Test
-
322,788 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

